Richard B. Egen
life sciences
maroon biotech
India
Biography
Mr. Egen is the former President and CEO of NephRx Corporation, a biotechnology company focused on acute renal failure. Mr. Egen brings a wealth of experience to Maroon Biotech. He spent seven years as President and CEO of Clintec International, a joint venture owned by Baxter International Inc. and Nestlé, S.A., engaged in the development and commercialization of clinical nutrition products. Prior to Clintec, Mr. Egen was a Senior Vice President and held various senior management positions during his fifteen year career with Baxter International Inc., in which he held responsibility for corporate strategic planning and all European operations. Mr. Egen is former Chairman of the Board of Aksys, Ltd. and serves on the Board of Directors of Väsamed.
Research Interest
Mr. Egen is the former President and CEO of NephRx Corporation, a biotechnology company focused on acute renal failure. Mr. Egen brings a wealth of experience to Maroon Biotech. He spent seven years as President and CEO of Clintec International, a joint venture owned by Baxter International Inc. and Nestlé, S.A., engaged in the development and commercialization of clinical nutrition products. Prior to Clintec, Mr. Egen was a Senior Vice President and held various senior management positions during his fifteen year career with Baxter International Inc., in which he held responsibility for corporate strategic planning and all European operations. Mr. Egen is former Chairman of the Board of Aksys, Ltd. and serves on the Board of Directors of Väsamed.
